BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 9447950)

  • 1. Anti-GAD antibodies in Chinese patients with youth and adult-onset IDDM and NIDDM.
    Thai AC; Ng WY; Loke KY; Lee WR; Lui KF; Cheah JS
    Diabetologia; 1997 Dec; 40(12):1425-30. PubMed ID: 9447950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase.
    Abiru N; Takino H; Yano M; Kawasaki E; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S
    J Autoimmun; 1996 Oct; 9(5):683-8. PubMed ID: 8933285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
    Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM?
    Schmidli RS; Colman PG; Harrison LC
    J Autoimmun; 1994 Dec; 7(6):873-9. PubMed ID: 7888043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune markers in slow type 1 diabetes: confrontation to type 1 diabetes.
    Desailloud R; Fajardy I; Vambergue A; Prevost G; Pigny P; Fontaine P
    Diabetes Metab; 2000 Nov; 26(5):353-60. PubMed ID: 11119014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
    Jaeger C; Allendörfer J; Hatziagelaki E; Dyrberg T; Bergis KH; Federlin K; Bretzel RG
    Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [GAD antibody in IDDM].
    Yokota I; Shima K
    Rinsho Byori; 1998 Apr; 46(4):331-7. PubMed ID: 9594623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects: relationship to age, sex and islet cell antibody status, and temporal profile.
    Schmidli RS; DeAizpurua HJ; Harrison LC; Colman PG
    J Autoimmun; 1994 Feb; 7(1):55-66. PubMed ID: 8198702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA).
    Lohmann T; Kellner K; Verlohren HJ; Krug J; Steindorf J; Scherbaum WA; Seissler J
    Diabetologia; 2001 Aug; 44(8):1005-10. PubMed ID: 11484077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
    Ishii M; Hasegawa G; Fukui M; Obayashi H; Ohta M; Ogata M; Yoshioka K; Kitagawa Y; Nakano K; Yoshikawa T; Nakamura N
    Immunol Lett; 2005 Jul; 99(2):180-5. PubMed ID: 16009268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase.
    Inukai T; Fujiwara Y; Tayama K; Aso Y; Ogino K; Takemura Y
    Exp Clin Endocrinol Diabetes; 1997; 105(6):327-30. PubMed ID: 9439927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
    Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S
    J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic characteristics of GAD-antibody positive patients initially diagnosed as having type 2 diabetes.
    Hamaguchi K; Kimura A; Kusuda Y; Yamashita T; Yasunami M; Takahasi M; Abe N; Yoshimatsu H
    Diabetes Res Clin Pract; 2004 Nov; 66(2):163-71. PubMed ID: 15533584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
    Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S
    J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CD38 autoantibodies: characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies.
    Mallone R; Ortolan E; Pinach S; Volante M; Zanone MM; Bruno G; Baj G; Lohmann T; Cavallo-Perin P; Malavasi F
    Diabetologia; 2002 Dec; 45(12):1667-77. PubMed ID: 12488956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies to glutamic acid decarboxylase and phenotypic features associated with early insulin treatment in individuals with adult-onset diabetes mellitus.
    Humphrey AR; McCarty DJ; Mackay IR; Rowley MJ; Dwyer T; Zimmet P
    Diabet Med; 1998 Feb; 15(2):113-9. PubMed ID: 9507910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics, and time course of pancreatic beta-cell function and glutamic acid decarboxylase antibodies in Thai patients with adult-onset Type 1 diabetes: distinction between patients of rapid- and slow-onset.
    Rattarasarn C; Diosdado MA
    Horm Metab Res; 1999 May; 31(5):311-6. PubMed ID: 10422726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to glutamic acid decarboxylase in Japanese diabetic patients with secondary failure of oral hypoglycaemic therapy.
    Fukui M; Nakano K; Shigeta H; Yoshimori K; Fujii M; Kitagawa Y; Mori H; Kajiyama S; Nakamura N; Abe N; Obayashi H; Fukui I; Ohta K; Ohta M; Kondo M
    Diabet Med; 1997 Feb; 14(2):148-52. PubMed ID: 9047093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glutamic acid decarboxylase autoantibodies (antiGAD-Ab) in patients with non-insulin dependent diabetes mellitus (NIDDM)].
    Martinka E; Straková J; Ocenásová A; Pullmannová D; Petrisková J; Mácková N; Sutarík L; Galajda P; Baláz D; Kerný J; Vladár L; Mokán M
    Vnitr Lek; 1998 Jan; 44(1):17-22. PubMed ID: 9750478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
    Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L
    Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.